| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Sedivention GmbH Devices for therapy and prevention Sedivention develops a break-through, widely applicable, device for interventional obesity therapy. Hunger is transmitted from the stomach to the brain by the gastric trunks of the vagal nerve. Sedivention is developing a cryo-balloon freezing the gastric branches of the vagal nerve from inside the stomach, in a procedure comparable to gastroscopy. The ambulatory intervention takes approximately 20 min. The costs of the intervention are far below costs of bariatric surgery without surgical morbidity and complications. In brief: Sedivention develops the first long-term effective, scalable therapy for obesity: No scars, no pain, no surgical complications, no … Type: | 1 | 1 | 0 | 1 |
 |  nanoshape GmbH nanoshape provides a new developed surface treatment for medical implants to reduce bacterial infection nanoshape is a German start-up with the mission to prevent implant-infections with innovative nanotechnology. Implant surfaces play a major role in implant anchorage and implant compatibility. Currently available implant systems usually have sandblasted and etched surfaces to enhance osseointegration (integration into surrounding bone tissue). In some cases functional coatings with other materials are applied. However, hardly any commercial implant systems have surfaces that can reduce the bacterial colonization. We have developed an innovative surface treatment that gives implants bacteria repellent properties. In this process, the topography … Type: | 1 | 1 | 1 | 3 |
 | POROUS Quantitative Ultrasound Based Cortical Bone Microstructure Analysis Osteoporosis accounts for more days in the hospital than breast cancer, heart attack, diabetes, and other diseases. Due to this fact, the cost that osteoporosis imposes on healthcare budgets is staggering. In 2010, European Union countries spent €37 billion (US$40 billion), while in 2015, the United States spent US$20 billion, a staggering total annual cost of US$60 billion and growing. Current measurement methods cannot detect the onset of osteoporosis but rather approximate the bone-loss associated relative fracture risk, typically at advanced stages of the disease progression. Early detection is vital because the highest … Type: | 3 | 1 | 2 | 15 |
 | DeepEn We build hair-thin microscopes for neuroscience and medicine. DeepEn offers hair-thin endomicroscopy solutions capable of subcellular resolution and high-speed observations within hard-to-access body regions. Our minimally invasive devices are used in research and diagnostics, helping to advance our understanding of diseases and microscopic processes deep inside sensitive tissues in real time. DeepEn was founded in 2024 as a spinoff from the Department for Holographic Endoscopy, led by Prof Dr Tomas Cizmar at Leibniz Institute of Photonic Technology in Jena, Germany. Our Managing Director is Dr Sergey Turtaev. For more information, visit deepenimaging.com | 2 | 1 | 1 | 4 |
 |  Acorai The new standard in heart failure management Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product can monitor intracardiac pressures non-invasively through a machine learning analysis of pressure dynamics in acoustics, vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization. Cardiology, Heart Failure, Heart Failure Monitoring, Non-invasive intracardiac pressure monitoring, Medical Device, AI, Machine Learning, Heart Failure Patient Workflow, ICPM, Prevent heart failure readmissions, Multi-sensor hardware, Pressure dynamics, … Type: | 7 | 3 | 3 | 26 |
 | Metabolon, Inc. Providing actionable biological insights to answer the toughest questions in life sciences research and drug development Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the … Type: | 0 | 0 | 0 | 228 |
 | Rebiotix Inc (a Ferring Company) A Ferring Company working to harness the power of the human microbiome to address unmet medical needs. Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com. Biotechnology, Microbiome, Drug Development, Medicine, Clinical Trials, Regulatory Innovation, Patient Support, Internal Medicine, Manufacturing, Infectious Disease, Gastroenterology, Emerging Diseases, and Novel Technology Type: | 0 | 0 | 0 | 98 |
 | European Federation of Allergy and Airways Diseases Patients' Associations (EFA) EFA is the voice of over 200 million people living with allergy, asthma and chronic obstructive pulmonary disease (COPD) The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is the voice of 200 million people living with allergy, asthma and chronic obstructive pulmonary disease (COPD) in Europe. We have 45 national associations of allergy, asthma and COPD patients in 26 European countries. Visit our European Allergy and Asthma Youth Parliament website, to advocate on the pressing issues for young patients! https://www.efanet.org/inform/youth-parliament Healthcare | Medicines and medical devices | Food labelling | Tobacco and smoking | Air quality | … Type: | 2 | 0 | 0 | 18 |
 | Scleroderma Research Foundation America's leading nonprofit investor in medical research aimed at finding better treatments and a cure for scleroderma. The Scleroderma Research Foundation (SRF) is America's leading nonprofit investor in medical research to discover improved treatments and a cure for scleroderma. Our collaborative model for medical research brings together the best in science and technology for the benefit of scleroderma patients. The SRF was established in 1987 by patient turned activist Sharon Monsky, when research on this potentially life threatening illness was nearly nonexistent. Since inception, we’ve stood firm in our belief that the best way to help scleroderma patients is to … Type: | 0 | 0 | 0 | 16 |
 | EU-LIFE Alliance of research institutes advocating for excellent research in Europe As an alliance of leading research centres in life sciences, we advocate for excellent research including a better value in and for Europe since our creation in 2013. Our 15 members are renowned research centres that operate with similar principles of excellence, external reviews, independence, competitiveness, and internationality. We decided to join forces to address complex questions, thereby contributing to improving European science. Science, Research, European Research Area, and Research Policy Type: | 6 | 1 | 5 | 8 |
 | Institute of Science and Technology Austria The Institute of Science and Technology Austria is dedicated to cutting-edge basic research and graduate education. The Institute of Science and Technology Austria (ISTA) is a young, international research institution dedicated to graduate education, science education, and cutting-edge research in the physical, mathematical, computer, and life sciences. Located in Klosterneuburg on the outskirts of Vienna, the Institute was opened in 2009. Currently, there are more than 70 research groups on campus. The Institute expects to reach its full capacity of 150 research groups by 2036. The governance and management structures of ISTA guarantee its independence and freedom from political and … Type: | 0 | 0 | 0 | 671 |
 | Iowa Biotechnology Association (IowaBio) Advancing Biotechnology Across Iowa. Since 1994, the Iowa Biotechnology Association has provided benefits and services to promote the interests and growth of the life sciences industries in Iowa. We are a non-profit, membership-based organization with a diversified membership including industry companies from all segments of biotechnology, universities & colleges, state & federal associations, as well as numerous service & support companies. Our Association seeks to promote the success and growth of biotech-based business in Iowa, ultimately securing our strong biotech economy while growing our business & increasing our influence nationally and around the globe. Type: | 2 | 0 | 2 | 8 |
 | Genedata Enterprise solutions to digitalize biopharma R&D Founded in 1997, Genedata delivers enterprise solutions to enable Biopharma R&D globally to discover, develop, and manufacture innovative biotherapeutics faster and more efficiently. Genedata combines computational, scientific, and technical expertise with extensive biopharma R&D domain knowledge to deliver user-friendly solutions that are scalable, open, and aligned with industry processes. Today, most of the leading pharmaceutical, biotechnology, and agrichemical companies, as well as innovative life science research institutions rely on Genedata. CGTs, Vaccines, Mass Spectrometry, NGS, BioInformatics, Biosafety, Bioprocess Development, Biologics, Software, Digitalization, Biopharma R&D, Precision Medicine, Workflow Automation, and Cell Line Development Type: | 0 | 0 | 0 | 375 |
 | ConcertAI Accelerating insights and outcomes for patients through leading RWD, AI technology and scientific expertise. The fastest growing AI-powered SaaS data company in healthcare. Real World Data, Precision Medicine, RWE, Artificial Intelligence, biopharma, Clinical Trials, Real World Evidence, SaaS, Patient Access, Patient Outcomes, Patient Insights, Technology, Scientific Expertise, Biomedical Innovators, Leading RWE, Clinical Development, and Enterprise Data Type: | 7 | 0 | 7 | 936 |
 | Reaction Biology Contract research organization with commitment to quality data and quality support. Let's Discover Together. Reaction Biology provides scientists worldwide with a trusted research partner supporting all phases of preclinical drug discovery from target validation through hit identification, hit to lead and lead optimization. Our portfolio covers most of your needs in drug discovery – over 2,000 biochemical targets, hundreds of cell-based assays, an extensive array of in vivo oncology models, along with custom assay development and protein production. Our team of Ph.D. scientists will provide you with collaborative support, quality data, and excellent communication, for a superior research result. Our … Type: | 1 | 1 | 0 | 146 |
 | Applied BioMath Model-Informed Drug Discovery and Development (MID3) services, software, and R&D company. Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Our Model-Aided Drug Invention (MADI) approach employs proprietary algorithms and software to support groups worldwide in decision-making from early research through clinical trials. The Applied BioMath team leverages their decades of expertise in biology, mathematical modeling and analysis, high-performance computing, and industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, patients, and the best … Type: | 1 | 0 | 0 | 54 |
 | Rally Foundation for Childhood Cancer Research Rally, a national 501(c)3 non-profit based in Atlanta, empowers volunteers across the country to raise awareness and fun Rally Foundation, a 501 (c)(3) non-profit organization, through volunteers across the country, raises awareness and funds specifically for childhood cancer research to find better treatments and cures for childhood cancers. According to audited financials Rally Foundation operates at 93% efficiency. Rally Foundation awards childhood cancer research grants based on a national competitive peer review process. Every school day in America 46 kids are diagnosed with cancer. Childhood cancer is the #1 disease killer of kids in America. Less than 4% of the … Type: | 1 | 0 | 1 | 37 |
 | Parker Institute for Cancer Immunotherapy Our mission is to accelerate the development of breakthrough immune therapies to turn all cancers into curable diseases Type: | 0 | 0 | 0 | N/A |
 | Oklahoma State Univ. Living out our land-grant mission through instruction, research and outreach since 1890.🤠 | 0 | 0 | 0 | N/A |
 | CTTI Mission: Develop & drive adoption of practices that increase quality/efficiency of #ClinicalTrials. Follows/RTs ≠ endorsements #InnovationThroughCollaboration | 0 | 0 | 0 | N/A |
 | Ajinomoto Bio-Pharma Services The Power to Make Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex® protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet … Type: | 0 | 0 | 0 | 764 |
 | Karyopharm Therapeutics Inc. Discovers, develops and commercializes novel, life-changing cancer therapies in disease areas with high unmet need. Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL). oncology, pharmaceutical, biotech, … Type: | 4 | 0 | 1 | 400 |
 | Diagnostics For Animals Federate and represent Manufacturers of Animal Health Diagnostics Promotes initiatives for the development of AHD Diagnostics For Animals is the only professional international #organization representing #animal #health #diagnostics. It federates and represents #manufacturers of animal health diagnostics at large, explains the benefit of an harmonized, efficient, and transparent regulatory framework to ensure the future #veterinary health industry and promotes initiatives for the development of animal health diagnostics health, animal, vet, veterinary, diagnostic, OneHealth, organization, livestock, pet, zoonosis, medical device, medical analysis, innovation, health security, research, and test Type: | 1 | 0 | 0 | 1 |
 | Nanna Therapeutics Totally Integrated Medicines Engine (TIME) to Cure Diseases Type: | 0 | 0 | 0 | N/A |
 | Mount Sinai Innovation Partners We facilitate the real-world application and commercialization of @MountSinaiNYC and @IcahnMountSinai discoveries and the development of research partnerships | 16 | 0 | 16 | N/A |
 | Technoclone Technoclone is a producer of #diagnostic tests, equipment and research products in the area of #blood #clotting At Technoclone we see innovation as our duty to help overcome new complexity in the diagnostics of hematological and cardio-vascular disorders. Today more than ever. Technoclone is a world-leading producer of diagnostics tests; equipment’s and research products in the area of blood clotting and offers one of the most complete product portfolios on the market. The Ceveron 100 series is the first fully automated coagulation analyzer series for clotting, chromogenic, turbidimetric assays, thrombin generation and quenching technology (as for FXIII & ADAMTS13 activity). … Type: | 0 | 0 | 0 | 20 |
 | Oncoheroes Biosciences A Biotech Company 100% Focused On Advancing New Therapies For Childhood Cancer A life science company exclusively focused on finding cures for childhood cancer by identifying and developing the most promising projects to create new treatments and drugs. drug development, clinical development, and childhood cancer Type: | 2 | 0 | 0 | 12 |
 | Vicore Pharma AB Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. AlmeeTM (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. … Type: | 0 | 0 | 0 | 36 |
 | Salvat Driven by innovation to contribute to a healthier and happier life We share a deep commitment to service and customer service, which, combined with our professionalism, helps us achieve our primary objective: giving a longer, healthier, happier life to society by offering safe and efficacious drugs. We are able to achieve this goal through research and analysis, as well as an understanding of the needs of our patients, professionals, distributors and institutional representatives. Medicamentos de prescripción, Nutraceuticos, and Productos farmacéuticos Type: | 0 | 0 | 0 | 355 |
 | biolution GmbH CONSULTING AND VISUAL SOLUTIONS FOR THE LIFE SCIENCES We are a team of life scientists and graphic designers with over 20 years of experience supporting researchers through consulting, funding and media design solutions. We offer a range of consulting and graphic design solutions, including: • Grant writing: We can help you write grant proposals for competitive research funds and grants on a national and EU level. We have a deep understanding of the grant application process and can help you craft a compelling proposal that will stand out from the competition. • Scientific communication: We can help you create high-quality … | 0 | 0 | 0 | 8 |
 | Gregor Mendel Institute The Gregor Mendel Institute of Molecular Plant Biology (GMI) was founded by the Austrian Academy of Sciences in 2000 in the form of a company to promote research excellence within the field of plant molecular biology. It is the only international centre for basic plant research in Austria. The GMI is located at the Vienna Biocenter within the purpose-built Austrian Academy of Sciences Life Sciences Center Vienna, completed in January 2006. plant molecular biology and genetics Type: | 0 | 0 | 0 | 90 |
 | peptides&elephants GmbH providing customized peptides , antigen peptides and peptidelibraries for immunological research peptides&elephants - We serve Peptides - for your perfect satisfaction with quality, price and support. Our major PEP-LIPS products are high parallel customized peptide libraries and peptide pools. PEP-LIPS are approved for T-Cell Stimulation Assays, Epitope Mapping, EliSpot Assays, Drug Discovery and Array Technology. The full range of Peptides and Peptidomimetica from the single to millions from linear to cyclic from short to overlong, from crude to high purity, from modified to labeled, from natural to non natural amino acids - peptides&elephants is your faithful partner. Please visit our … Type: | 1 | 0 | 1 | 7 |
 | NBS Scientific FR [Automatic translation follows] We provide you with the necessary resources to make new discoveries in the laboratory. We provide all the resources necessary for the development of new perspectives in the laboratories. Insights leading to discoveries that could change the landscape of public health, well-being and security worldwide. By equipping yourself with our innovative sample collection, storage and tracking, liquid handling and automation products, you can improve and optimize your laboratory workflows to achieve more accurate results, faster. Beyond our product offering, we also strive to help you identify and solve the daily challenges in your laboratory. By taking the … Type: | 0 | 0 | 0 | 3 |
 | PhoreMost Ltd Drugging the Undruggable® PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identification platform can discern the best new targets for future therapy and crucially, how to drug them, which has the potential to significantly increase the diversity and affordability of novel therapeutics for cancer and other unmet diseases. PhoreMost is building a pipeline of novel drug discovery programmes aimed at addressing a range of diseases, with a mission to accelerate, diversify and rationalise drug discovery. Using … Type: | 4 | 0 | 1 | 55 |
 | DCU Life Sciences Institute www.dcu.ie/lifesciences Dublin City University's Life Sciences Institute | 0 | 0 | 0 | 13 |
 | Trutino Biosciences ON DEMAND CYTOKINE Company Trutino means ‘Balance’ in Latin, and this represents our strategy, namely an Rx/Dx approach for Precision Oncology Drug & Clinical Development. The company logo symbolizes well balanced wings. As it takes both wings to fly, we believe a balanced Rx/Dx drug development will ultimately deliver on the promise of Precision Oncology. Our effort focuses on ‘targeted destruction of cancer cells’ and simultaneous ‘differential activation of tumor-specific immune cells’ to maximize treatment response. ON DEMAND CYTOKINE, CYTOKINE DRUG, IMMUNO-ONCOLOGY, and TARGETED ONCOLOGY Type: | 0 | 0 | 0 | 16 |
 | Enterprise Therapeutics Dedicated to the development of novel therapies to improve the lives of patients with respiratory disease Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life. The leadership team has significant expertise in drug discovery, drug development, respiratory biology and ion channel pharmacology. … Type: | 1 | 1 | 1 | 13 |
 | National Scleroderma Foundation A relentless force in finding a cure and improving the lives of people affected by scleroderma. The National Scleroderma Foundation is a 501(c)(3) nonprofit organization founded in 1998 to advance medical research, promote disease awareness, and provide support and education to people with scleroderma, their families and support networks. Supported by a network of thousands of individuals across the United States, the Foundation helps those living with scleroderma by providing support and education at the same time that it funds peer-reviewed scleroderma research. Since its founding, the Foundation has committed over $30 Million to discover the cause, understand the mechanism, … Type: | 0 | 0 | 0 | 76 |
 | NutriQuest Our Promise: Ingenuity Inspired by Servitude NutriQuest®, founded in 2007, is a team of industry-leading animal experts serving producers by delivering targeted breakthrough solutions. The NutriQuest team has a passion for understanding producer’s needs. That passion is combined with an unending curiosity and drive to develop innovative products and services. A high dedication to research and long term relationships give customers confidence they are provided a high value from their NutriQuest products or services. At NutriQuest we feel privileged to have a leadership role in the animal industry and have a strong sense of stewardship for animal production. Through collaboration … | 0 | 0 | 0 | 50 |
 | CeMM The Research Center for Molecular Medicine of the Austrian Academy of Sciences. CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences is an international, independent and interdisciplinary research institute. CeMM is pursuing applied research in the field of molecular medicineby merging basic and clinical research of cancer, inflammatory processes and immunological diseases. The focus of interest of CeMM are people and their diseases. CeMM uses the knowledge from basic and clinical research to develop innovative therapeutic and diagnostic strategies. Located at the Vienna General Hospital (AKH), the largest medical research complex in Austria, it acts as … Type: | 3 | 0 | 3 | 284 |
 | Parc Científic de Barcelona [Automatic translation follows] Where Science becomes Business Located in the knowledge campus, the PCB provides you with basic ordinary services and a privileged environment for networking. More than 2,700 highly qualified researchers work at the PCB; join our community! | 5 | 2 | 3 | 109 |
 | Biognosys Transforming life sciences with cutting-edge proteomics technology and solutions The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. Our Solutions We offer a versatile portfolio of proprietary proteomics services, software, and kits. We make these widely available for pharmaceutical and biotechnology researchers and proteomics experts. Our solutions provide a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human … Type: | 3 | 0 | 3 | 85 |
 | T3 Pharmaceuticals AG Developing the next generation bacterial cancer therapy Developing the next generation bacterial cancer therapy The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments. Despite significant advances of classical therapies, there remains a high need for novel and innovative medicines to treat cancer. T3 Pharmaceuticals is dedicated to fill this gap by developing highly specific and efficient treatments using live bacteria. T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein … Type: | 1 | 1 | 0 | 22 |
 | National Centre for Biological Sciences We are a premier research institute based in Bangalore, and part of the Tata Institute of Fundamental Research (TIFR). The National Centre for Biological Sciences (NCBS), located in Bangalore, is part of the Tata Institute of Fundamental Research. The mandate of NCBS is fundamental research in the frontier areas of biology. Research interests range from the study of single molecules to ecology and evolution. Along with inStem and C-CAMP it forms the Bangalore Bio-Cluster, bringing together fundamental research, translational studies, and technology development. We are a premier research institute with all the necessary facilities that a research scientist may need. … Type: | 1 | 0 | 1 | 399 |
 | BiomX Inc Customized phage therapies to eradicate harmful bacteria in chronic diseases BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. Microbiome, Biotechnology, Drug Discovery, and Phage Therapies Type: | 1 | 0 | 1 | 76 |
 | EFMC - European Federation for Medicinal Chemistry and Chemical Biology Promoting European Medicinal Chemistry and Chemical Biology on the Global Stage The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders. Type: | 2 | 0 | 0 | 18 |
 | Neumomadrid [Automatic translation follows] Madrid Society of Pulmonology and Thoracic Surgery The Madrid Society of Pulmonology and Thoracic Surgery (Pneumomadrid) is a scientific association that brings together health professionals dedicated to the study and research of diseases of the respiratory system, as well as their prevention and clinical care. Pneumology Type: | 2 | 0 | 2 | 10 |
 | Max Planck Institute for Medical Research How to observe and manipulate molecular and cellular interactions? Research and people at the MPIMR. Tweets by press office. Type: | 0 | 0 | 0 | N/A |
 | Cognito Therapeutics, Inc. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases. Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer’s disease and expects to start pivotal studies in 2022. The company’s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT. Type: | 6 | 0 | 3 | 57 |
 | Oxford PharmaGenesis Providing innovative services to the healthcare industry, professional societies and patient groups. Oxford PharmaGenesis is a HealthScience communications consultancy. We are the largest independently owned and financed company in the medical communications sector. Founded in 1998, our award-winning organization now comprises more than 500 talented people working from offices and homes worldwide. We are connected by a strong company culture and a clear mission: to accelerate adoption of evidence-based innovations for patients in areas of unmet medical need. Contact us to find out how we apply powerful thinking, dedicated to your success. Medical affairs, Commercial and Marketing, Value demonstration, Real-world … Type: | 1 | 0 | 1 | 502 |
 | Cytune Pharma SAS A biotechnology company shaping the future of cancer #immunotherapies by translating compelling science into patient benefit. Member of @PPFGroup | 0 | 0 | 0 | 2 |
 | Kymera Therapeutics Inventing a new class of medicines using Targeted Protein Degradation Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged … Type: | 2 | 0 | 1 | 207 |
 | SOLNATIDE project H2020 project exploring safety, tolerability and clinical efficacy of solnatide IMP in COVID-19 patients. The SOLNATIDE project will clinically test the safety, tolerability and clinical efficacy of solnatide IMP in patients with severe COVID-19 requiring mechanical ventilation. APEPTICO’s lead-compound solnatide IMP has been designed for the therapeutic treatment of patients with Acute Respiratory Distress Syndrome (ARDS) and various forms of Pulmonary Oedema (PPO). Orally inhaled solnatide has delivered clinical proof-of-concept in one Phase I and two Phase IIa clinical studies (EUDRACT No. 2011-000223-33, 2012-001863-64 and 2013-000716-21). Currently, solnatide is subject to a Phase IIB trial (EUDRACT No. 2017-003855-47) being approved … Type: | 0 | 0 | 0 | N/A |
 | APEIRON Biologics AG Improving the lives of patients with next generation therapies for cancer and respiratory disease, including COVID-19. APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. Our company has a well balanced portfolio with one product on the market and several promising products from clinical to pre-clinical stages. As for the product on the market, APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients. We out-licensed Qarziba® globally to EUSA Pharma … | 0 | 0 | 0 | 11 |
 | Proxygen Closing the gaps in drug discovery Proxygen is a Vienna-based startup that develops therapies against cancer and other life-threatening diseases by reprogramming the cellular protein quality control system. We are focused on particular small molecules called “molecular glue degraders” which mediate recruitment of a disease-causing protein to a ubiquitin ligase. Consequently, the target protein is ubiquitinated and directed to the proteasome for degradation. Hence, instead of merely blocking the function of harmful proteins, molecular glue degraders enable their complete, targeted and selective elimination. This outlines a clear avenue towards targeting otherwise undruggable proteins and is therefore seen as one of … Type: | 1 | 0 | 0 | 38 |
 | OXGENE A WuXi Advanced Therapies company, based in Oxford, UK. OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENETM is headquartered in Oxford, UK. For additional information, please visit our website. PRODUCTS: Largest collection of standardised plasmids on the market and SERVICES: DNA Services, Protein Production Services, Virus Services, Cell Line Development Services. Type: | 3 | 0 | 0 | 63 |
 | ASCIL Biopharm We make injectable products better Ascil Biopharm is a Drug Delivery System company specialized in Long Acting Injectables (LAI) and devices. Our Research and development is focused in Controlled Release Formulations (CRF) and precision medical devices to enhance efficiency, safety, and patient convenience. Controlled Release Formulations, Long Acting Injectables, Drug Delivery Systems, and Parenteral Type: | 0 | 0 | 0 | 24 |
 | Enara Bio Advancing cancer immunotherapy by targeting the unconventional Enara Bio is shining a light on Dark Antigen® and T-cell biology to develop cancer immunotherapies designed to improve treatment outcomes for broad populations of cancer patients. Our pioneering EDAPT® platform enables us to discover novel cancer-specific antigens from previously uncharted genomic ‘dark matter’. The result is a growing database of Dark Antigens that can address the unmet need for cancer-specific targets that are homogenously expressed and highly prevalent in solid tumors. We are advancing multiple approaches to exploit these Dark Antigen targets, with an internal focus on TCR-directed immunotherapies, and additional therapeutic … Type: | 6 | 1 | 3 | 62 |
 | Axonis Therapeutics Axonis Therapeutics is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders Axonis Therapeutics is a Boston-based, neuro-focused biotechnology company developing first- and best-in-class medicines targeting KCC2, the critical mediator of inhibition within the brain, by translating breakthrough discoveries spun out from Boston Children’s Hospital, Harvard and Laval University. We are an exceptional team of drug hunters and target biology experts who have built a proprietary KCC2 discovery engine based on several years of world-leading know-how, to become the leaders in this potential blockbuster drug space. A venBio portfolio company, Axonis has raised $34+M in dilutive Seed funding, and … Type: | 5 | 0 | 3 | 19 |
 | Gubra Science of certainty Founded in 2008, we are a biotech company with two primary areas of business: Preclinical contract research organization (CRO) services and proprietary early target and drug discovery programs. Our focus is the metabolic space (e.g. obesity, diabetes, NASH and gastrointestinal diseases), where we specialize in peptide chemistry, in vivo pharmacology, ex vivo assays, molecular pharmacology, histology, imaging, stereology, NGS (next generation sequencing) and bioinformatics. Gubra is an abbreviation for GUt and BRAin, the original key focus areas of our research and expertise. We work with some of the most interesting and loyal partners and customers from across … Type: | 2 | 0 | 2 | 243 |
 | ArtiQ Providing AI software to optimize clinical trials and enhance diagnostic processes to improve patients' lives worldwide ArtiQ, a spin-off from the Belgian university KU Leuven, is a leading innovative software company dedicated to enhancing the diagnosis and monitoring of patients with respiratory conditions. Moreover, ArtiQ strives to streamline and optimize respiratory clinical trials for pharmaceutical companies. Through the development and provision of cutting-edge AI-first software, ArtiQ empowers traditional respiratory devices and processes. In April 2024, ArtiQ joined forces with Clario, a leading healthcare research and technology company. This collaboration allows ArtiQ to broaden its reach globally across various clinical trials … Type: | 5 | 1 | 4 | 21 |
 | GBM - Gesellschaft für Biochemie und Molekularbiologie e.V. The GBM is an association of about 5000 scientists working in the field of Molecular Life Sciences. The (German) Society for Biochemistry and Molecular Biology (Gesellschaft für Biochemie und Molekularbiologie, GBM) is the association of about 5000 scientists working in the field of Molecular Life Sciences. Most members of the GBM are German scientists from universities, industry and other research institutions, covering the entire spectrum of basic and applied Molecular Life Sciences. The aim of the GBM is to promote basic and applied research as well as education in the fields of biochemistry, molecular biology and molecular medicine. As the … Type: | 6 | 0 | 4 | 4 |
 | G1 Therapeutics, Inc. Our mission is to discover, develop and deliver next generation cancer therapies. G1 Therapeutics, Inc. is a commercial-stage oncology company focused on the development and commercialization of next generation anti-cancer therapies. Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first commercial product, COSELA® (trilaciclib). G1 is also executing a development program, with a deep clinical pipeline evaluating targeted cancer therapies in a variety of solid tumors, including breast, lung, and … Type: | 1 | 0 | 0 | 91 |
 | EFMI-European Federation for Medical Informatics The European Federation for Medical Informatics Association (EFMI) is the leading organisation in medical informatics in Europe and represents 32 countries. EFMI is organized as a nonprofit organisation concerned with the theory and practice of Information Science and Technology within Health and Health Science in a European context. The objectives when founded in 1976 were: - To advance international co-operation and dissemination of information in Medical Informatics on a European basis; - To promote high standards in the application of medical informatics; - To promote research and development in medical informatics; - To encourage high standards in education in medical … Type: | 0 | 0 | 0 | 20 |
 | Biome Diagnostics Advancing cancer care through microbiome profiling Biome Diagnostics GmbH (BiomeDx®) is an Austrian based MedTech company committed to advance precision medicine by pioneering microbiome-based technologies that transform cancer care. The company is strategically positioned at the intersection of state-of-the-art DNA sequencing and advanced machine learning algorithms to develop first in class technologies for routine clinical practice. Additionally to the lifestyle product myBioma (www.mybioma.com) for end-customers, the company focuses on the development of medically certified products in the area of gut microbiome and cancer. As safety and health of patients are top priorities, the company has already been repeatedly certified according … Type: | 4 | 0 | 3 | 16 |
 | FAU Erlangen-Nürnberg Moving knowledge. One of Germany‘s oldest and most distinguished universities: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU). We offer 40,000 students from around the world the ideal innovation-driven environment to kick-start their careers in Engineering, Business, Natural Sciences, Medicine, Law, & the Humanities. Stay in touch with your FAU and join our international alumni network free of charge: www.community.fau.de FAU Alumni Network - We are family! www.alumni.fau.de Type: | 0 | 0 | 0 | 4,364 |
 | The Science Advisory Board The source of discovery and development in the life sciences. The Science Advisory Board is a global community of scientists and medical professionals from around the world. Manufacturers of laboratory instruments and consumables, pharmaceutical and medical device companies, financial institutions and government agencies rely on the perspectives of our members when making important decisions. life science, molecular biology, cell biology, molecular diagnostics, drug discovery, bioprocessing, clinical chemistry, microbiology, proteomics, genomics, gene therapy, immunology, medicinal chemistry, stem cell biology, pathology, and analytical chemistry Type: | 17 | 0 | 17 | 11 |
 | Vienna Science and Technology Fund (WWTF) The Vienna Science and Technology Fund is a non-profit organisation to promote science and research in Vienna. The WWTF is the largest private non-profit research funder in Austria. Its mission is to fund cutting-edge scientific projects, while at the same time aiming to retain excellent young researchers in Vienna. Since 2003, the WWTF has invested more than €230 million in Viennese science through numerous highly competitive calls. Type: | 0 | 0 | 0 | 10 |
 | AFFiRiS AG Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains. From us for you. We are a clinical-stage biotechnology company that strives to challenge established treatment options for neurodegenerative diseases in order to preserve the quality of life of patients. WE FOCUS ON UNMET MEDICAL NEEDS IN CHRONIC DISEASES Currently available treatments for many neurodegenerative diseases aim to manage symptoms, and do not stop disease progression. As a result, neurodegenerative diseases often lead to a reduced quality of life. Better treatments for these diseases are needed to give patients healthier, happier, and longer lives. We aim to develop therapeutic and … Type: | 0 | 0 | 0 | 5 |
 | PIUR IMAGING GmbH Taking your ultrasound to the next dimension PIUR IMAGING, an Austrian medtech company, which is active in the field of diagnostic ultrasound imaging and is specialized in acquisition and visualization of 3D ultrasound images. PIUR IMAGINGs vision is it to provide access to affordable high-quality healthcare through AI-driven tomographic ultrasound solutions – everywhere! PIUR ́s tomographic ultrasound solution PIUR tUS Infinity turns any standard ultrasound system into a tomographic 3D imaging device, enabling true AI in ultrasound. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated. While standard ultrasound requires on-the-spot assessment of the images, PIUR ́s … Type: | 0 | 0 | 0 | 31 |
 | FH Campus Wien | University of Applied Sciences Hochschule für Zukunftsthemen With more than 8,000 students, FH Campus Wien is the largest university of applied sciences in Austria. The departments of Applied Nursing Science, Applied Life Sciences, Building and Design, Health Sciences, Social Work, Engineering as well as Administration, Economics, Security, Politics offer a choice of more than 60 part-time and full-time bachelor’s and master’s degree programs as well as master’s courses. FH Campus Wien is made up of three campuses and five partner locations. Training partnerships exist with the Vienna Health Association, the Vinzenz Group, the Nursing Academy of the Barmherzige Brüder, the Federal Ministry of Finance, … Type: | 5 | 0 | 5 | 1,145 |
 | University of Vienna Genuinely curious. Since 1365. With about 10,000 employees in teaching, research and administration, the University of Vienna is one of the largest employers in Vienna. At 20 faculties and centres, our employees work on new solutions for a better future by asking themselves complex questions every day with curiosity, passion and perseverance. The tasks and projects are as diverse as the research and teaching opportunities. Our employees appreciate both the exchange with young people and their contribution to international cutting-edge research, as well as flexible working hours and open cooperation. In addition to the Main Building of the University of … Type: | 0 | 0 | 0 | 6,468 |
 | Delta4ai Delta4 is a Vienna-based biotech startup driving the forefront of digital drug discovery and development. Delta4 is driving the forefront of digital drug discovery and development. We leverage on a proprietary computational analytics platform "Hyper-C", combining straightforward biomedical testing and clinical validation of candidate drugs. Our unique approach integrates iterative big data/in silico and experimental screens, offering the most efficient matching of clinical indications and compound/drug effect. drug repositioning, drug discovery, compounds, orphan diseases, indication expansion, AI, and omics Type: | 4 | 0 | 0 | 10 |
 | Nanoform Global experts in nanotechnology and drug particle engineering Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The company focuses on reducing clinical attrition and on enhancing drug molecules’ performance through its nanoforming technologies and formulation services. Nanoform’s capabilities include GMP manufacturing, and its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications. Type: | 10 | 0 | 4 | 157 |
 | Intercept Pharmaceuticals Our mission is to build a healthier tomorrow for patients with rare and serious liver diseases. We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is … Type: | 0 | 0 | 0 | 391 |
 | Enanta Pharmaceuticals Our vision is to transform the lives of patients with curative therapies. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs for virology and immunology indications. Enanta’s research and development programs are currently focused on respiratory syncytial virus (RSV) and chronic spontaneous urticaria (CSU) and the company has previously advanced clinical-stage compounds for SARS-CoV-2 (COVID-19) and chronic hepatitis B virus (HBV) infection. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic hepatitis c virus (HCV) … Type: | 2 | 0 | 2 | 162 |
 | Terns Pharmaceuticals Taking the Journey Towards Comprehensive Treatment of Serious Disease Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline includes three clinical-stage development programs including an allosteric BCR-ABL inhibitor, a small-molecule GLP-1 receptor agonist, a THR-β agonist and preclinical GIPR modulator programs. For more information, please visit: www.ternspharma.com. Disclaimer: Reposts and posts of contents are for informational purposes only and do not constitute endorsements or promotions of any third-party products, services or organizations (including any statements, views or conducts by such organizations) unless explicitly stated … Type: | 0 | 0 | 0 | 65 |
 | Oxford BioTherapeutics Redefining the cancer-immune synapse for novel immune checkpoint mechanisms Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies designed to fulfil major unmet patient needs in cancer therapeutics. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076's dual mechanism of action allows it to act as a 'primer' to re-engage the patient's immune system while at the same time targeting cancer cells directly. OBT’s proprietary OGAP® target discovery platform … Type: | 1 | 0 | 1 | 52 |
 | Sixfold Bioscience RNA delivery, evolved. RNA delivery, evolved. Drug delivery, RNA, and RNA delivery Type: | 4 | 0 | 3 | 35 |
 | Federation of European Neuroscience Societies - FENS Connecting European Neuroscience FENS, the Federation of European Neuroscience Societies,represents national European neuroscience societies and several monodisciplinary societies. FENS was founded in 1998 with the goals of advancing research and education in neuroscience and of representing neuroscience research to the public, other scientific societies and decison and policy-makers across Europe. FENS mission is to promote and support Neuroscience in Europe and around the world. neuroscience Type: | 4 | 2 | 2 | 53 |
 | INCLIVA Instituto de Investigación Sanitaria [Automatic translation follows] Integrating talent, improving your quality of life The INCLIVA Health Research Institute's mission is to “Encourage, promote, coordinate and execute quality research, integrating the basic and clinical aspects of the research process, with the aim of contributing to improving the health and quality of life of citizens. ”. Through the application of translational research, which ranges from laboratory studies to clinical trials, INCLIVA's vision is “to become a reference center at a national and international level in the prioritized fields of biomedical research, through management of excellence.” , which allows the optimization of the use of resources … | 4 | 0 | 4 | 249 |
 | Kineta KA (Nasdaq) Developing next-generation immunotherapies for cancer patients! Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience | 4 | 0 | 3 | 31 |
 | Alto Neuroscience Precision medicine for the brain is here. Alto Neuroscience is redefining psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective medicines, helping patients get better faster. Alto's Precision Psychiatry PlatformTM measures biomarkers like EEG and wearable data, behavioral patterns, genetics, and other factors to match patients with the treatment they are most likely to respond to. Our approach matches the right patient with the right Alto drug based on AI-derived brain biomarkers, redefining psychiatry at a time when the world needs it most. Type: | 3 | 0 | 3 | 75 |
 | Karuna Therapeutics Pushing the boundaries of neuroscience to transform the treatment of mental illness. Karuna Therapeutics, Inc. is now part of Bristol Myers Squibb. Learn about how we are continuing to transform the lives of patients with neurological and neuropsychiatric diseases @Bristol Myers Squibb or www.bms.com. Type: | 3 | 1 | 3 | 172 |
 | CenExel A leading nationwide clinical research site network pursing life-changing therapies committed to better patient outcomes CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites’ commitment to real world solutions. Rely on us to … Type: | 9 | 0 | 1 | 712 |
 | Edinburgh Innovations Edinburgh Innovations is the University of Edinburgh’s commercialisation service. We make ideas work for a better world. Edinburgh Innovations is the University of Edinburgh's commercialisation service. We benefit society and the economy by helping researchers, students and industry drive innovation. We seek opportunities, we build partnerships for mutual benefit, we make the journey easy, and we add value at every stage. Sponsored research, Industrial studentships, Technology licensing, University spin-out / start-up company formation, Access to academic expertise, Commercial use of research facilities, and Industry engagement Type: | 3 | 1 | 2 | 160 |
 | ZS | Intomics ZS | Intomics is a highly specialized biomedical data analytics company. We derive core biological insights from analysis and integration of biomedical big data. We increase the success rate of drug discovery and development projects for clients in the pharmaceutical industry. With our world-leading expertise, unique value-added data sets and sophisticated systems biology platform, we help our clients with: • Discovering new biomarkers • Assessing the specificity of biomarkers • Linking biomarkers to the underlying biology • Identifying drug targets and MOA • Delivering personalized medicine solutions • Repositioning of drugs • Creating biological knowledge maps for data-driven decision-making To … Type: | 3 | 1 | 1 | 14,534 |
 | Kymos Group Analytical CRO devoted to bioanalysis and quality control of small molecules, biologics and nucleic acids Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones: i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines. ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies. iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing) iv) Process analytical technology services, using NIR and RAMAN and QbD strategies. Kymos is certified in GLP's … Type: | 7 | 1 | 0 | 168 |
 | InterAx Biotech Advanced integration of biological systems, math models and artificial intelligence The company, a spin-out of ETH Zurich and the Paul Scherrer Institute, Switzerland, uses high throughput biochemical screening of compounds integrated into an artificial intelligence and cell pathways mathematical modeling process. This platform unlocks previously intractable targets, shortens timelines for drug discovery from years to months and reduces risks. The company focuses on the generation and optimization of drugs which trigger a specific and well characterized effect on signaling pathways, thus leading to higher therapeutic efficacy and reduced risk of toxicity. The company is specialized in GPCR drug discovery and … Type: | 4 | 0 | 3 | 17 |
 | Dentaid Oral Health. Better Life Global company leading in research with one purpose: to improve people’s oral health. We transform science and research into new solutions for oral healthcare. Higiene bucal and investigación y desarrollo Type: | 3 | 0 | 0 | 527 |
 | ArrePath Deciphering biology, discovering new classes of anti-infectives. ArrePath is a biotech company discovering and developing new and differentiated classes of anti-infectives to address antimicrobial resistance (AMR) through the application of state of the art technologies and novel strategies. We apply world-class science and innovation in imaging and AI / ML technologies to identify and develop novel drugs to address global health issues. Our advanced machine learning (ML) and imaging-based drug discovery platform enables a rapid and efficient identification of new drug classes with desired activity profiles and clinical utility, coupled with a deep understanding of mechanism of action at the … Type: | 1 | 0 | 1 | 17 |
 | Shimadzu Scientific Instruments Providing innovative, proven products for a wide range of laboratories and applications Headquartered in Columbia, Maryland, Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation (Kyoto, Japan), a world leader in the development of scientific instruments. SSI was established in 1975 as a distribution center providing analytical solutions to a wide range of laboratories and lab services providers in the Americas. Today, SSI’s focus has expanded greatly beyond distribution. SSI maintains a network of ten regional offices strategically located across the United States, with experienced technical specialists, service and sales engineers situated throughout the country; a state-of-the-art Customer … Type: | 0 | 0 | 0 | 692 |
 | DeNovix Inc. We design, manufacture and sell award-winning lab equipment for today's life scientists. DeNovix Inc., founded in 2012, is a Wilmington, DE, USA based instrumentation company that develops, manufactures and sells laboratory equipment to meet the demands of today’s evolving life science research. DeNovix focuses on providing innovative products and outstanding customer support. The company is equipped with the financial, commercial and technical resources to deliver breakthrough products for research success. DeNovix products include the DS-11 Series Spectrophotometer / Fluorometer, the CellDrop Automated Cell Counter, the QFX Fluorometer and DeNovix assays. Our instruments are stand-alone (no PC needed) and built on … Type: | 1 | 0 | 1 | 27 |
 | PHC Corporation of North America Life Science Innovator Since 1966 PHC Corporation of North America (PHCNA) is headquartered in Wood Dale, IL and manufactures and markets PHCbi brand laboratory equipment. PHCNA is a subsidiary of PHC Holdings Corporation of Tokyo, Japan, a global diversified life sciences, diagnostics, and medical device company. For more than 50 years, PHCNA has met the needs of pharmaceutical, biotechnology, hospital/clinical, and industrial customers, offering a unique perspective on scientific research. We play a critical role in global product development across a range of research areas and have a deeply entrenched reputation as a manufacturer of highly-reliable quality and innovative laboratory … Type: | 3 | 0 | 0 | 198 |
 | SCARLETRED Holding GmbH SCARLETRED is the leading expert in AI assisted skin monitoring and objective image analysis SCARLETRED is a MedTech company transforming the global dermatology market. Our CE approved medical device platform Scarletred®Vision is the first AI powered skin image analysis software supplied to Biopharma, Health Care and Cosmetics Industry enabling to develop better products much faster. The patented technology facilitates standardized skin documentation and remote tracking via mobile App. Images can be uploaded in a cloud based platform and objectively analyzed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis or wound healing. The application … Type: | 0 | 0 | 0 | 15 |
 | Platomics The Industry Accelerator for In Vitro Diagnostics Innovation to patient, faster Platomics enables in vitro diagnostic manufacturers and laboratories to bring safe and effective innovations to market with unparalleled speed and efficiency. Our global platform for generating and marketing compliant IVD products is equipped with intelligent regulatory automation that allows our clients to seamlessly overcome regulatory challenges over the entire life cycle of their products. Personalized Medicine, Next Generation Sequencing, Infrastructure Provider, Artificial Intelligence, Software Developer, Bioinformatics, and Cloud Computing | 0 | 0 | 0 | 97 |
 | University of Natural Resources and Life Sciences, Vienna (BOKU) Offizieller Account der BOKU University The University of Natural Resources and Life Sciences, Vienna is one of the leading universities for life sciences in Europe. We see ourselves as an innovation leader in sustainable development and in the creation of a green economy in cooperation with research, education, economics and society. Forschung, Lehre, Innovation, Studium, Wissenschaft, and Bildung Type: | 1 | 0 | 0 | 1,520 |
 | invIOs INNOVATIVE IMMUNO-ONCOLOGY Developing tomorrow's cancer therapies. Today. invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the … Type: | 0 | 0 | 0 | 23 |
 | Eveliqure Biotechnologies Eveliqure Biotechnologies is developing novel vaccines for the prevention of diarrhoeal diseases. Eveliqure Biotechnologies is an innovative biotech company developing novel vaccines for the prevention of diarrhoeal diseases both for travellers and people living in endemic regions of low- and middle-income countries. Eveliqure is a game-changer amongst vaccine companies, championing novel technologies to make the world safe from diarrhoea. Eveliqure is passionate about improving the quality of life for both the poor and the privileged by providing innovative medical solutions that fight diarrhoeal diseases. Type: | 0 | 0 | 0 | 5 |
 | ÖGMBT - Austrian Association of Molecular Life Sciences and Biotechnology Austrian scientific non-profit association, representing over 1.300 members in academia and industry. The ÖGMBT is a scientific non-profit association. We represent over 1.300 personal members and around 90 companies and institutions in the field of molecular life sciences and biotechnology in Austria. Our goal is to link the entire scientific spectrum, ranging from basic to applied science, academia and industry as well as government and media. A particular emphasis is set on the support of young scientists. Type: | 3 | 0 | 0 | 4 |
Startup